Radiomics on 177Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT Comparison
{{output}}
177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) is an established therapeutic option for patients with neuroendocrine tumors (NETs). Although radiomics has been increasingly applied in NET research, it was developed almost exclusively using 68Ga-DO... ...
